Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    74,000

Stocks News & Analysis

stocks

Wide moat share expects luck to turn

A tough year for jackpots however earnings are expected to normalise.
stocks

ASX share’s growth story intact despite supply constraints

Short term supply challenges but Chinese growth story remains intact.
stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,269.7013.70-0.15%
CAC 408,484.4331.340.37%
DAX 4026,136.56153.520.59%
Dow JONES (US)53,277.01517.800.98%
FTSE 10010,816.5668.400.64%
HKSE26,009.46310.971.21%
NASDAQ26,180.46113.290.43%
Nikkei 22566,016.36200.43-0.30%
NZX 50 Index13,972.6652.840.38%
S&P 5007,674.3733.210.43%
S&P/ASX 2009,058.906.90-0.08%
SSE Composite Index3,905.201.480.04%

Market Movers